Anti-fibrotic action in respiratory tract infections
The latest studies have shown that 1-MNA reduces substantially pulmonary fibrosis and has anti-inflammatory effects.
In a model of pulmonary fibrosis induced by bleomycin, it was demonstrated that 1-MNA reduced pulmonary fibrosis by 28%. In this model, 1-MNA was more effective than reference drugs (nintedanib and fluticasone).